Why the study?
The molecular mechanisms underlying reactive fibrosis and cardiomyocyte disconnection in myocardial remodeling remain incompletely understood, limiting therapeutic opportunities.
Does titin cleavage trigger myocardial remodeling in a mouse model?
Does titin cleavage trigger myocardial remodeling in a mouse model?
Titin cleavage is sufficient to trigger rapid myocardial remodeling, including cardiomyocyte disengagement and reactive fibrosis, highlighting a potential mechanism in chemotherapy-induced cardiotoxicity and ischemic damage.
Titin cleavage may drive mouse remodeling; hypothesis-generating for chemotherapy cardiotoxicity or ischemia mechanisms, pending human studies.
Myocardial remodeling including cardiomyocyte-death-independent, reactive fibrosis and disconnection of cardiomyocytes is at the basis of prevalent cardiac conditions converging into arrhythmias and heart failure. However, the molecular mechanisms behind these pathogenic responses remain incompletely understood limiting therapeutic opportunities. Here, we find that a molecular event common to unrelated heart diseases, namely the cleavage of the sarcomeric protein titin, is enough to trigger fast myocardial remodeling. Using an engineered system based on the expression of tobacco etch virus protease (TEVp) in mice, we show that 30% mosaic cardiac titin cleavage leads to global cardiomyocyte disengagement, activation of cardiac fibroblasts and interstitial collagen deposition. These effects are concurrent, involve ERK1/2 signaling, and are expected to contribute, at least, to myocardial remodeling in chemotherapy-induced cardiotoxicity and ischemia damage.
No takes yet. Share an insight, caveat, or question.
López‐Unzu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: